Filing Details

Accession Number:
0001610717-23-000205
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-07-18 18:26:55
Reporting Period:
2023-07-14
Accepted Time:
2023-07-18 18:26:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1770787 10X Genomics Inc. TXG Laboratory Analytical Instruments (3826) 455614458
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1786720 Serge Saxonov 10X Genomics, Inc.
6230 Stoneridge Mall Road
Pleasanton CA 94588
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2023-07-14 851 $57.61 890,154 No 4 S Direct
Class A Common Stock Disposition 2023-07-14 1,149 $58.37 889,005 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class A Common Stock 27 Indirect See footnote
Class A Common Stock 870 Indirect See footnote
Class A Common Stock 183,350 Indirect See footnote
Class A Common Stock 16,320 Indirect See footnote
Footnotes
  1. The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on December 13, 2022.
  2. This transaction was executed in multiple trades at prices ranging from $57.02 to $58.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  3. This transaction was executed in multiple trades at prices ranging from $58.02 to $58.73. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  4. The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
  5. The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee.
  6. The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
  7. The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.